Disc Medicine, Inc. NASDAQ:IRON

Disc Medicine stock price today

$58.18
-5.94
-9.26%
Financial Health
0
1
2
3
4
5
6
7
8
9

Disc Medicine stock price monthly change

+35.93%
month

Disc Medicine stock price quarterly change

+35.93%
quarter

Disc Medicine stock price yearly change

+10.69%
year

Disc Medicine key metrics

Market Cap
1.88B
Enterprise value
N/A
P/E
-2.38
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
0.90
PEG ratio
-0.02
EPS
-3.41
Revenue
N/A
EBITDA
-95.86M
Income
-80.59M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Disc Medicine stock price history

Disc Medicine stock forecast

Disc Medicine financial statements

Average Price Target
Last Year

$77.67

Potential upside: 33.49%

Based on estimate of 6 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Disc Medicine, Inc. (NASDAQ:IRON): Profit margin
Jun 2023 0 -15.94M
Sep 2023 0 -14.12M
Dec 2023 0 -23.57M
Mar 2024 0 -26.94M
Disc Medicine, Inc. (NASDAQ:IRON): Debt to assets
Jun 2023 384174000 12.95M 3.37%
Sep 2023 376497000 17.52M 4.65%
Dec 2023 367996000 22.87M 6.22%
Mar 2024 354182000 16.11M 4.55%
Disc Medicine, Inc. (NASDAQ:IRON): Cash Flow
Jun 2023 -12.72M -12K 153.85K
Sep 2023 -7.47M -45K 460
Dec 2023 -17.79M -3K 7.75K
Mar 2024 -33.59M -67K 15.9M

Disc Medicine alternative data

Disc Medicine, Inc. (NASDAQ:IRON): Employee count
Aug 2023 51
Sep 2023 55
Oct 2023 55
Nov 2023 55
Dec 2023 60
Jan 2024 60
Feb 2024 60
Mar 2024 74
Apr 2024 74
May 2024 74
Jun 2024 78
Jul 2024 78

Disc Medicine other data

81.79% -18.21%
of IRON is owned by hedge funds
850.15K -10.58M
shares is hold by hedge funds

Disc Medicine, Inc. (NASDAQ:IRON): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 252500
Mar 2024 0 26157
Apr 2024 0 2560
May 2024 0 201
Jun 2024 388891 1957
Jul 2024 0 201
Aug 2024 0 201
Sep 2024 0 4957
Oct 2024 0 201
Nov 2024 0 30678
Dec 2024 0 34568
Transaction Date Insider Security Shares Price per share Total value Source
Option
QUISEL JOHN D director, officer: Chief Execut..
Common Stock 19,820 $2.65 $52,523
Sale
QUISEL JOHN D director, officer: Chief Execut..
Common Stock 3,414 $62.38 $212,958
Sale
QUISEL JOHN D director, officer: Chief Execut..
Common Stock 12,194 $63.12 $769,673
Sale
QUISEL JOHN D director, officer: Chief Execut..
Common Stock 4,212 $63.8 $268,734
Option
QUISEL JOHN D director, officer: Chief Execut..
Stock Option (Right to Buy) 19,820 $2.65 $52,523
Option
QUISEL JOHN D director, officer: Chief Execut..
Stock Option (Right to Buy) 12,791 $1.01 $12,919
Option
QUISEL JOHN D director, officer: Chief Execut..
Common Stock 12,791 $1.01 $12,919
Sale
QUISEL JOHN D director, officer: Chief Execut..
Common Stock 219 $64.66 $14,160
Sale
QUISEL JOHN D director, officer: Chief Execut..
Common Stock 5,767 $65.58 $378,194
Sale
QUISEL JOHN D director, officer: Chief Execut..
Common Stock 6,305 $66.35 $418,362
Monday, 9 December 2024
globenewswire.com
Sunday, 8 December 2024
globenewswire.com
Wednesday, 13 November 2024
globenewswire.com
Friday, 8 November 2024
globenewswire.com
Monday, 4 November 2024
globenewswire.com
Friday, 1 November 2024
globenewswire.com
Friday, 25 October 2024
globenewswire.com
Friday, 11 October 2024
globenewswire.com
Thursday, 19 September 2024
globenewswire.com
Friday, 30 August 2024
globenewswire.com
Thursday, 29 August 2024
prnewswire.com
Friday, 14 June 2024
seekingalpha.com
globenewswire.com
globenewswire.com
Thursday, 30 May 2024
globenewswire.com
Tuesday, 14 May 2024
globenewswire.com
Monday, 13 May 2024
GlobeNewsWire
Tuesday, 2 April 2024
Zacks Investment Research
Benzinga
Wednesday, 3 January 2024
GlobeNewsWire
Monday, 13 November 2023
Zacks Investment Research
Wednesday, 8 November 2023
GlobeNewsWire
Wednesday, 30 August 2023
GlobeNewsWire
Friday, 11 August 2023
Zacks Investment Research
Tuesday, 25 July 2023
Zacks Investment Research
Friday, 9 June 2023
Seeking Alpha
Thursday, 1 June 2023
The Motley Fool
Friday, 5 May 2023
Zacks Investment Research
Friday, 21 April 2023
GlobeNewsWire
Wednesday, 19 April 2023
Zacks Investment Research
  • What's the price of Disc Medicine stock today?

    One share of Disc Medicine stock can currently be purchased for approximately $58.18.

  • When is Disc Medicine's next earnings date?

    Unfortunately, Disc Medicine's (IRON) next earnings date is currently unknown.

  • Does Disc Medicine pay dividends?

    No, Disc Medicine does not pay dividends.

  • How much money does Disc Medicine make?

    Disc Medicine has a market capitalization of 1.88B.

  • What is Disc Medicine's stock symbol?

    Disc Medicine, Inc. is traded on the NASDAQ under the ticker symbol "IRON".

  • What is Disc Medicine's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Disc Medicine?

    Shares of Disc Medicine can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Disc Medicine have?

    As Jul 2024, Disc Medicine employs 78 workers, which is 5% more then previous quarter.

  • When Disc Medicine went public?

    Disc Medicine, Inc. is publicly traded company for more then 5 years since IPO on 12 Aug 2020.

  • What is Disc Medicine's official website?

    The official website for Disc Medicine is discmedicine.com.

  • Where are Disc Medicine's headquarters?

    Disc Medicine is headquartered at 321 Arsenal Street, Watertown, MA.

  • How can i contact Disc Medicine?

    Disc Medicine's mailing address is 321 Arsenal Street, Watertown, MA and company can be reached via phone at +61 76749274.

  • What is Disc Medicine stock forecast & price target?

    Based on 6 Wall Street analysts` predicted price targets for Disc Medicine in the last 12 months, the avarage price target is $77.67. The average price target represents a 33.49% change from the last price of $58.18.

Disc Medicine company profile:

Disc Medicine, Inc.

discmedicine.com
Exchange:

NASDAQ

Full time employees:

82

Industry:

Biotechnology

Sector:

Healthcare

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.

321 Arsenal Street
Watertown, MA 02472

CIK: 0001901203
ISIN: US2546041011
: